poisar

Stocks · News reference

Wells Fargo Maintains Overweight on Tectonic Therapeutic, Lowers Price Target to $93

Benzinga Newsdesk

Wells Fargo analyst Tiago Fauth maintains Tectonic Therapeutic (NASDAQ:TECX) with a Overweight and lowers the price target from $101 to $93.

More stocks newsConnected markets

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

TECX
Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Benzinga Newsdesk

    Tectonic Therapeutic Q2 EPS $(1.18) Beats $(1.37) Estimate

    Tectonic Therapeutic (NASDAQ:TECX) reported quarterly losses of $(1.18) per share which beat the analyst consensus estimate of $(1.37) by 13.87 percent. This is a 10.28 percent decrease over losses of $(1.07) per share

    TECX
  2. SEC EDGAR

    8-K filing — Tectonic Therapeutic, Inc. (TECX)

    Filed: 2026-06-10 AccNo: 0001193125-26-266040 Size: 173 KB Item 5.07: Submission of Matters to a Vote of Security Holders Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

    TECX